RT @SGriffin_Lab
This is most welcome news...urgently needed. Thanks @NICEComms
The EU approved #Evusheld for use in March 2022...that's almost a year where people achieved a degree of parity.
V concerned that remdesivir and sotrovimab may be withdrawn, however...
https://www.reuters.com/world/uk/britains-nice-speed-up-reviews-covid-19-treatments-2023-02-16/